CEE ENDOCONNECT meeting
11–12 May 2015
Prague, Czech Republic
Agenda
Monday 11th May – afternoon
1345
1400
1410
Welcome and introduction
Welcome from the host country
Genetic heritage of hypopituitarism in Central and
Eastern Europe
Symposium 1 – GH therapy during transition and beyond
1440
Why continue GH?
1510
Who, how and when to test for permanent GH
deficiency?
1540
How to treat GH deficiency during transition and in
adulthood
1610
Coffee
Symposium 2 – Long-term safety review of GH treatment
1630
Introduction to the symposium
1645
Outputs from the ESPE/PES/GRS 2015 consensus
summary:
• Paediatric perspective
• Adult perspective
1745
1815
Panel discussion
Close
EBT/GEN/15/06-c
Date of preparation: March 2015
Roy Gomez
Michal Krsek
Jan Lebl
Chair: Jan Lebl
Anton Luger
Mohamed Maghnie
Fahrettin Kelestimur
Chair: Moshe Philip
Moshe Philip
Lars Savendahl
1st: Gudmundur Johansson
2nd: Richard Ross
3rd: Jens Christiansen
4th: Eva Marie Erfruth
Moshe Philip
Tuesday 12th May – morning
0830 Welcome to day 2
Symposium 3 – Turner Syndrome from childhood to adulthood
0840 Paediatric perspective
0900 Adult perspective
0920
Panel discussion
Paediatric endocrinology stream
Chair: Feyza Darendeliler
Catch-up growth
Physiology of
0930
Jan Maarten Wit
catch-up
0950 Nutrition
Moshe Phillip
1010 Catch-up with GH
Michael Ranke
1030 Coffee
Feyza
Case-based
1050
Darendeliler, Jan
discussion
Lebl
1st: Martin Savage
Optimising GH
2nd: Anita Hokken
therapy in
Koelega
1220
paediatric age
3rd: Maithe
group
Tauber
1250
Growth prediction
models
1330
Lunch
Michael Ranke
Tuesday 12th May – afternoon
0930
1000
Adult endocrinology stream
Chair: Michael Buchfelder
Historical
perspectives on
Wouter de Herder
acromegaly
Recent advances in
Michael
pituitary surgery
Buchfelder
1050
Case-based
discussion
Vera Popovic,
Martha Korbonits
1220
What does
treatment success
look like?
Felipe Casanueva
1250
Multidisciplinary
approach to
management of
acromegaly
Vaclav Hana
Symposium 4 – Gigantism and acromegaly
1430
Latest understanding of aetiology and pathogenesis
1500
A review of the recent treatment guidelines for
acromegaly
1530
Long-term follow-up
1600
Closing remarks
EBT/GEN/15/06-c
Date of preparation: March 2015
Chair: Jan Maarten Wit
Feyza Darendeliler
1st: Claus Gravholt
2nd: Gerry Conway
Chair: Miklos Goth
Marta Korbonits
Vera Popovic
Marija Pfeifer
TBD